Endo International Ordinary Shares reported $192.46M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Aerie Pharmaceuticals AERI:US USD 33.88M 5.73M
Amarin AMRN:US USD 4.39M 82.51M
Ani Pharmaceuticals ANIP:US USD 30.08M 1.88M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Coherus Biosciences CHRS:US USD 44.83M 6.44M
Eli Lilly And LLY:US USD 1.61B 10.9M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Hikma Pharmaceutical HIK:LN USD 256M 0
Horizon Pharma HZNP:US USD 397.56M 658K
Lannett LCI:US USD 16.7M 9.06M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Merk MRK:US USD 2.47B 13M
Novartis NOVN:VX USD 3.4B 185M
Pacira Pharmaceuticals PCRX:US USD 61.28M 3.72M
Perrigo Ordinary Shares PRGO:US USD 281M 57.1M
Pfizer PFE:US USD 3.54B 345M
Phibro Animal Health PAHC:US USD 54.96M 576K
Revance Therapeutics RVNC:US USD 64.09M 17.91M
Supernus Pharmaceuticals SUPN:US USD 224.63M 124.15M
Takeda 4502:JP JPY 248.73B 17.25B
Teva Pharmaceutical TEVA:IT USD 777M 72M
Xeris Pharmaceuticals Inc XERS:US USD 34.49M 1.51M
Zoetis ZTS:US USD 501M 28M